Fusion Gene Studies
in Kim Lab

FusionBase FusionGDB FusionGDB2 FusionPDB FusionNeoAntigen FusionAI FusionNW FGviewer Publication Contact
FusionGDB Logo

Home

Download

Statistics

Examples

Help

Contact
Center for Computational Systems Medicine
leaf

Fusion Gene Summary

leaf

Fusion Gene ORF analysis

leaf

Fusion Genomic Features

leaf

Fusion Protein Features

leaf

Fusion Gene Sequence

leaf

Fusion Gene PPI analysis

leaf

Related Drugs

leaf

Related Diseases

Fusion gene:FOS-FOS (FusionGDB2 ID:HG2353TG2353)

Fusion Gene Summary for FOS-FOS

check button Fusion gene summary
Fusion gene informationFusion gene name: FOS-FOS
Fusion gene ID: hg2353tg2353
HgeneTgene
Gene symbol

FOS

FOS

Gene ID

2353

2353

Gene nameFos proto-oncogene, AP-1 transcription factor subunitFos proto-oncogene, AP-1 transcription factor subunit
SynonymsAP-1|C-FOS|p55AP-1|C-FOS|p55
Cytomap('FOS')('FOS')

14q24.3

14q24.3

Type of geneprotein-codingprotein-coding
Descriptionproto-oncogene c-FosFBJ murine osteosarcoma viral (v-fos) oncogene homolog (oncogene FOS)FBJ murine osteosarcoma viral oncogene homologFos proto-oncogene, AP-1 trancription factor subunitG0/G1 switch regulatory protein 7activator protein 1cellular oproto-oncogene c-FosFBJ murine osteosarcoma viral (v-fos) oncogene homolog (oncogene FOS)FBJ murine osteosarcoma viral oncogene homologFos proto-oncogene, AP-1 trancription factor subunitG0/G1 switch regulatory protein 7activator protein 1cellular o
Modification date2020032920200329
UniProtAcc..
Ensembl transtripts involved in fusion geneENST00000303562, ENST00000555686, 
ENST00000535987, ENST00000555347, 
ENST00000554617, ENST00000555242, 
ENST00000556324, 		ENST00000303562, 
ENST00000535987, ENST00000554617, 
ENST00000555242, ENST00000555347, 
ENST00000555686, ENST00000556324, 
Fusion gene scores* DoF score6 X 9 X 1=5410 X 13 X 3=390
# samples 913
** MAII scorelog2(9/54*10)=0.736965594166206
effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs).
DoF>8 and MAII>0		log2(13/390*10)=-1.58496250072116
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
Context

PubMed: FOS [Title/Abstract] AND FOS [Title/Abstract] AND fusion [Title/Abstract]

Most frequent breakpointFOS(75748643)-FOS(75748498), # samples:1
FOS(75747659)-FOS(75745716), # samples:1
FOS(75746257)-FOS(75746322), # samples:1
FOS(75748367)-FOS(75747739), # samples:1
Anticipated loss of major functional domain due to fusion event.FOS-FOS seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF.
FOS-FOS seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF.
FOS-FOS seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF.
FOS-FOS seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF.
FOS-FOS seems lost the major protein functional domain in Hgene partner, which is a transcription factor due to the frame-shifted ORF.
FOS-FOS seems lost the major protein functional domain in Tgene partner, which is a transcription factor due to the frame-shifted ORF.
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types
** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10)

check button Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez
PartnerGeneGO IDGO termPubMed ID
HgeneFOS

GO:0007179

transforming growth factor beta receptor signaling pathway

9732876

HgeneFOS

GO:0034614

cellular response to reactive oxygen species

17217916

HgeneFOS

GO:0045893

positive regulation of transcription, DNA-templated

9732876

HgeneFOS

GO:0045944

positive regulation of transcription by RNA polymerase II

10508860

HgeneFOS

GO:0060395

SMAD protein signal transduction

9732876

TgeneFOS

GO:0007179

transforming growth factor beta receptor signaling pathway

9732876

TgeneFOS

GO:0034614

cellular response to reactive oxygen species

17217916

TgeneFOS

GO:0045893

positive regulation of transcription, DNA-templated

9732876

TgeneFOS

GO:0045944

positive regulation of transcription by RNA polymerase II

10508860

TgeneFOS

GO:0060395

SMAD protein signal transduction

9732876


check buttonFusion gene breakpoints across FOS (5'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure
check buttonFusion gene breakpoints across FOS (3'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure

check button Fusion gene information
* All genome coordinats were lifted-over on hg19.
* Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser.
SourceDiseaseSampleHgeneHchrHbpHstrandTgeneTchrTbpTstrand


Top

Fusion Gene ORF analysis for FOS-FOS

check button Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure.
* Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser.
ORFHenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrand

check buttonORFfinder result based on the fusion transcript sequence of in-frame fusion genes.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandSeq length
(transcript)		BP loci
(transcript)		Predicted start
(transcript)		Predicted stop
(transcript)		Seq length
(amino acids)

check buttonDeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandNo-coding scoreCoding score

Top

Fusion Genomic Features for FOS-FOS


check buttonFusionAI prediction of the potential fusion gene breakpoint based on the pre-mature RNA sequence context (+/- 5kb of individual partner genes, total 20kb length sequence). FusionAI is a fusion gene breakpoint classifier based on convolutional neural network by comparing the fusion positive and negative sequence context of ~ 20K fusion gene data. From here, we can have the relative potentency of the 20K genomic sequence how individual sequnce will be likely used as the gene fusion breakpoints.
HgeneHchrHbpHstrandTgeneTchrTbpTstrand1-pp (fusion gene breakpoint)

check buttonDistribution of 44 human genomic features loci across 20kb length fusion breakpoint regions. We integrated a total of 44 different types of human genomic feature loci information across five big categories including virus integration sites, repeats, structural variants, chromatin states, and gene expression regulation. More details are in help page.
genomic feature

Top

Fusion Protein Features for FOS-FOS


check button Four levels of functional features of fusion genes
Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr14:75748643/chr14:75748498)
- FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels.
- How to search
1. Put your fusion gene symbol.
2. Press the tab key until there will be shown the breakpoint information filled.
4. Go down and press 'Search' tab twice.
4. Go down to have the hyperlink of the search result.
5. Click the hyperlink.
6. See the FGviewer result for your fusion gene.
FGviewer

check buttonMain function of each fusion partner protein. (from UniProt)
HgeneTgene
..
FUNCTION: Transcriptional activator which is required for calcium-dependent dendritic growth and branching in cortical neurons. Recruits CREB-binding protein (CREBBP) to nuclear bodies. Component of the CREST-BRG1 complex, a multiprotein complex that regulates promoter activation by orchestrating a calcium-dependent release of a repressor complex and a recruitment of an activator complex. In resting neurons, transcription of the c-FOS promoter is inhibited by BRG1-dependent recruitment of a phospho-RB1-HDAC1 repressor complex. Upon calcium influx, RB1 is dephosphorylated by calcineurin, which leads to release of the repressor complex. At the same time, there is increased recruitment of CREBBP to the promoter by a CREST-dependent mechanism, which leads to transcriptional activation. The CREST-BRG1 complex also binds to the NR2B promoter, and activity-dependent induction of NR2B expression involves a release of HDAC1 and recruitment of CREBBP (By similarity). {ECO:0000250}.FUNCTION: Transcriptional activator which is required for calcium-dependent dendritic growth and branching in cortical neurons. Recruits CREB-binding protein (CREBBP) to nuclear bodies. Component of the CREST-BRG1 complex, a multiprotein complex that regulates promoter activation by orchestrating a calcium-dependent release of a repressor complex and a recruitment of an activator complex. In resting neurons, transcription of the c-FOS promoter is inhibited by BRG1-dependent recruitment of a phospho-RB1-HDAC1 repressor complex. Upon calcium influx, RB1 is dephosphorylated by calcineurin, which leads to release of the repressor complex. At the same time, there is increased recruitment of CREBBP to the promoter by a CREST-dependent mechanism, which leads to transcriptional activation. The CREST-BRG1 complex also binds to the NR2B promoter, and activity-dependent induction of NR2B expression involves a release of HDAC1 and recruitment of CREBBP (By similarity). {ECO:0000250}.

check buttonRetention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at

download page


* Minus value of BPloci means that the break pointn is located before the CDS.
- In-frame and retained protein feature among the 13 regional features.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenProtein featureProtein feature note
TgeneFOSchr14:75747659chr14:75745716ENST0000030356204137_2000381.0DomainbZIP
TgeneFOSchr14:75747659chr14:75745716ENST0000030356204139_1590381.0RegionNote=Basic motif%3B required for the activation of phospholipid synthesis%2C but not for CDS1-binding
TgeneFOSchr14:75747659chr14:75745716ENST0000030356204165_1930381.0RegionLeucine-zipper

- In-frame and not-retained protein feature among the 13 regional features.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenProtein featureProtein feature note
HgeneFOSchr14:75747659chr14:75745716ENST00000303562+14137_2000381.0DomainbZIP
HgeneFOSchr14:75747659chr14:75745716ENST00000303562+14139_1590381.0RegionNote=Basic motif%3B required for the activation of phospholipid synthesis%2C but not for CDS1-binding
HgeneFOSchr14:75747659chr14:75745716ENST00000303562+14165_1930381.0RegionLeucine-zipper


Top

Fusion Gene Sequence for FOS-FOS


check button For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. To have fusion amino acid sequence, we ran ORFfinder and chose the longest ORF among the all predicted ones.

Top

Fusion Gene PPI Analysis for FOS-FOS


check button Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in

ChiPPI page.


check button Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160)
HgeneHgene's interactorsTgeneTgene's interactors


check button - Retained PPIs in in-frame fusion.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenStill interaction with


check button - Lost PPIs in in-frame fusion.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenInteraction lost with


check button - Retained PPIs, but lost function due to frame-shift fusion.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenInteraction lost with


Top

Related Drugs for FOS-FOS


check button Drugs targeting genes involved in this fusion gene.
(DrugBank Version 5.1.8 2021-05-08)
PartnerGeneUniProtAccDrugBank IDDrug nameDrug activityDrug typeDrug status

Top

Related Diseases for FOS-FOS


check button Diseases associated with fusion partners.
(DisGeNet 4.0)
PartnerGeneDisease IDDisease name# pubmedsSource
HgeneFOSC0022333Jacksonian Seizure4CTD_human
HgeneFOSC0036572Seizures4CTD_human
HgeneFOSC0038220Status Epilepticus4CTD_human
HgeneFOSC0149958Complex partial seizures4CTD_human
HgeneFOSC0234533Generalized seizures4CTD_human
HgeneFOSC0234535Clonic Seizures4CTD_human
HgeneFOSC0270823Petit mal status4CTD_human
HgeneFOSC0270824Visual seizure4CTD_human
HgeneFOSC0270844Tonic Seizures4CTD_human
HgeneFOSC0270846Epileptic drop attack4CTD_human
HgeneFOSC0311335Grand Mal Status Epilepticus4CTD_human
HgeneFOSC0393734Complex Partial Status Epilepticus4CTD_human
HgeneFOSC0422850Seizures, Somatosensory4CTD_human
HgeneFOSC0422852Seizures, Auditory4CTD_human
HgeneFOSC0422853Olfactory seizure4CTD_human
HgeneFOSC0422854Gustatory seizure4CTD_human
HgeneFOSC0422855Vertiginous seizure4CTD_human
HgeneFOSC0494475Tonic - clonic seizures4CTD_human
HgeneFOSC0751056Non-epileptic convulsion4CTD_human
HgeneFOSC0751110Single Seizure4CTD_human
HgeneFOSC0751123Atonic Absence Seizures4CTD_human
HgeneFOSC0751494Convulsive Seizures4CTD_human
HgeneFOSC0751495Seizures, Focal4CTD_human
HgeneFOSC0751496Seizures, Sensory4CTD_human
HgeneFOSC0751522Status Epilepticus, Subclinical4CTD_human
HgeneFOSC0751523Non-Convulsive Status Epilepticus4CTD_human
HgeneFOSC0751524Simple Partial Status Epilepticus4CTD_human
HgeneFOSC3495874Nonepileptic Seizures4CTD_human
HgeneFOSC4048158Convulsions4CTD_human
HgeneFOSC4316903Absence Seizures4CTD_human
HgeneFOSC4317109Epileptic Seizures4CTD_human
HgeneFOSC4317123Myoclonic Seizures4CTD_human
HgeneFOSC4505436Generalized Absence Seizures4CTD_human
HgeneFOSC0009171Cocaine Abuse3CTD_human
HgeneFOSC0038587Substance Withdrawal Syndrome3CTD_human
HgeneFOSC0086189Drug Withdrawal Symptoms3CTD_human
HgeneFOSC0087169Withdrawal Symptoms3CTD_human
HgeneFOSC0236736Cocaine-Related Disorders3CTD_human
HgeneFOSC0600427Cocaine Dependence3CTD_human
HgeneFOSC0020538Hypertensive disease2CTD_human
HgeneFOSC2239176Liver carcinoma2CTD_human
HgeneFOSC0003469Anxiety Disorders1CTD_human
HgeneFOSC0005398Cholestasis, Extrahepatic1CTD_human
HgeneFOSC0006142Malignant neoplasm of breast1CTD_human
HgeneFOSC0007621Neoplastic Cell Transformation1CTD_human
HgeneFOSC0011859Lipoatrophic Diabetes Mellitus1ORPHANET
HgeneFOSC0014175Endometriosis1CTD_human
HgeneFOSC0014544Epilepsy1CTD_human
HgeneFOSC0016063Osteitis Fibrosa Disseminata1CTD_human
HgeneFOSC0019080Hemorrhage1CTD_human
HgeneFOSC0020429Hyperalgesia1CTD_human
HgeneFOSC0023893Liver Cirrhosis, Experimental1CTD_human
HgeneFOSC0024121Lung Neoplasms1CTD_human
HgeneFOSC0027765nervous system disorder1CTD_human
HgeneFOSC0035126Reperfusion Injury1CTD_human
HgeneFOSC0040997Trigeminal Neuralgia1CTD_human
HgeneFOSC0086237Epilepsy, Cryptogenic1CTD_human
HgeneFOSC0087031Juvenile-Onset Still Disease1CTD_human
HgeneFOSC0149504Encephalopathy, Toxic1CTD_human
HgeneFOSC0154659Toxic Encephalitis1CTD_human
HgeneFOSC0221032Familial generalized lipodystrophy1ORPHANET
HgeneFOSC0235032Neurotoxicity Syndromes1CTD_human
HgeneFOSC0236018Aura1CTD_human
HgeneFOSC0236733Amphetamine-Related Disorders1CTD_human
HgeneFOSC0236804Amphetamine Addiction1CTD_human
HgeneFOSC0236807Amphetamine Abuse1CTD_human
HgeneFOSC0238281Middle Cerebral Artery Syndrome1CTD_human
HgeneFOSC0242379Malignant neoplasm of lung1CTD_human
HgeneFOSC0269102Endometrioma1CTD_human
HgeneFOSC0376280Anxiety States, Neurotic1CTD_human
HgeneFOSC0393786Trigeminal Neuralgia, Idiopathic1CTD_human
HgeneFOSC0393787Secondary Trigeminal Neuralgia1CTD_human
HgeneFOSC0458247Allodynia1CTD_human
HgeneFOSC0678222Breast Carcinoma1CTD_human
HgeneFOSC0740376Middle Cerebral Artery Thrombosis1CTD_human
HgeneFOSC0740391Middle Cerebral Artery Occlusion1CTD_human
HgeneFOSC0740392Infarction, Middle Cerebral Artery1CTD_human
HgeneFOSC0751111Awakening Epilepsy1CTD_human
HgeneFOSC0751211Hyperalgesia, Primary1CTD_human
HgeneFOSC0751212Hyperalgesia, Secondary1CTD_human
HgeneFOSC0751213Tactile Allodynia1CTD_human
HgeneFOSC0751214Hyperalgesia, Thermal1CTD_human
HgeneFOSC0751217Hyperkinesia, Generalized1CTD_human
HgeneFOSC0751845Middle Cerebral Artery Embolus1CTD_human
HgeneFOSC0751846Left Middle Cerebral Artery Infarction1CTD_human
HgeneFOSC0751847Embolic Infarction, Middle Cerebral Artery1CTD_human
HgeneFOSC0751848Thrombotic Infarction, Middle Cerebral Artery1CTD_human
HgeneFOSC0751849Right Middle Cerebral Artery Infarction1CTD_human
HgeneFOSC1257931Mammary Neoplasms, Human1CTD_human
HgeneFOSC1279420Anxiety neurosis (finding)1CTD_human
HgeneFOSC1458155Mammary Neoplasms1CTD_human
HgeneFOSC1862939AMYOTROPHIC LATERAL SCLEROSIS 11CTD_human
HgeneFOSC1862941Amyotrophic Lateral Sclerosis, Sporadic1CTD_human
HgeneFOSC2936719Mechanical Allodynia1CTD_human
HgeneFOSC3495559Juvenile arthritis1CTD_human
HgeneFOSC3714758Juvenile psoriatic arthritis1CTD_human
HgeneFOSC3887506Hyperkinesia1CTD_human
HgeneFOSC4551993Amyotrophic Lateral Sclerosis, Familial1CTD_human
HgeneFOSC4552091Polyarthritis, Juvenile, Rheumatoid Factor Negative1CTD_human
HgeneFOSC4704862Polyarthritis, Juvenile, Rheumatoid Factor Positive1CTD_human
HgeneFOSC4704874Mammary Carcinoma, Human1CTD_human
HgeneFOSC4704884Fibrocystic Dysplasia of Bone1CTD_human
HgeneFOSC4704885Fibrocartilaginous Dysplasia of Bone1CTD_human
HgeneFOSC4721610Carcinoma, Ovarian Epithelial1CTD_human
TgeneC0022333Jacksonian Seizure4CTD_human
TgeneC0036572Seizures4CTD_human
TgeneC0038220Status Epilepticus4CTD_human
TgeneC0149958Complex partial seizures4CTD_human
TgeneC0234533Generalized seizures4CTD_human
TgeneC0234535Clonic Seizures4CTD_human
TgeneC0270823Petit mal status4CTD_human
TgeneC0270824Visual seizure4CTD_human
TgeneC0270844Tonic Seizures4CTD_human
TgeneC0270846Epileptic drop attack4CTD_human
TgeneC0311335Grand Mal Status Epilepticus4CTD_human
TgeneC0393734Complex Partial Status Epilepticus4CTD_human
TgeneC0422850Seizures, Somatosensory4CTD_human
TgeneC0422852Seizures, Auditory4CTD_human
TgeneC0422853Olfactory seizure4CTD_human
TgeneC0422854Gustatory seizure4CTD_human
TgeneC0422855Vertiginous seizure4CTD_human
TgeneC0494475Tonic - clonic seizures4CTD_human
TgeneC0751056Non-epileptic convulsion4CTD_human
TgeneC0751110Single Seizure4CTD_human
TgeneC0751123Atonic Absence Seizures4CTD_human
TgeneC0751494Convulsive Seizures4CTD_human
TgeneC0751495Seizures, Focal4CTD_human
TgeneC0751496Seizures, Sensory4CTD_human
TgeneC0751522Status Epilepticus, Subclinical4CTD_human
TgeneC0751523Non-Convulsive Status Epilepticus4CTD_human
TgeneC0751524Simple Partial Status Epilepticus4CTD_human
TgeneC3495874Nonepileptic Seizures4CTD_human
TgeneC4048158Convulsions4CTD_human
TgeneC4316903Absence Seizures4CTD_human
TgeneC4317109Epileptic Seizures4CTD_human
TgeneC4317123Myoclonic Seizures4CTD_human
TgeneC4505436Generalized Absence Seizures4CTD_human
TgeneC0009171Cocaine Abuse3CTD_human
TgeneC0038587Substance Withdrawal Syndrome3CTD_human
TgeneC0086189Drug Withdrawal Symptoms3CTD_human
TgeneC0087169Withdrawal Symptoms3CTD_human
TgeneC0236736Cocaine-Related Disorders3CTD_human
TgeneC0600427Cocaine Dependence3CTD_human
TgeneC0020538Hypertensive disease2CTD_human
TgeneC2239176Liver carcinoma2CTD_human
TgeneC0003469Anxiety Disorders1CTD_human
TgeneC0005398Cholestasis, Extrahepatic1CTD_human
TgeneC0006142Malignant neoplasm of breast1CTD_human
TgeneC0007621Neoplastic Cell Transformation1CTD_human
TgeneC0011859Lipoatrophic Diabetes Mellitus1ORPHANET
TgeneC0014175Endometriosis1CTD_human
TgeneC0014544Epilepsy1CTD_human
TgeneC0016063Osteitis Fibrosa Disseminata1CTD_human
TgeneC0019080Hemorrhage1CTD_human
TgeneC0020429Hyperalgesia1CTD_human
TgeneC0023893Liver Cirrhosis, Experimental1CTD_human
TgeneC0024121Lung Neoplasms1CTD_human
TgeneC0027765nervous system disorder1CTD_human
TgeneC0035126Reperfusion Injury1CTD_human
TgeneC0040997Trigeminal Neuralgia1CTD_human
TgeneC0086237Epilepsy, Cryptogenic1CTD_human
TgeneC0087031Juvenile-Onset Still Disease1CTD_human
TgeneC0149504Encephalopathy, Toxic1CTD_human
TgeneC0154659Toxic Encephalitis1CTD_human
TgeneC0221032Familial generalized lipodystrophy1ORPHANET
TgeneC0235032Neurotoxicity Syndromes1CTD_human
TgeneC0236018Aura1CTD_human
TgeneC0236733Amphetamine-Related Disorders1CTD_human
TgeneC0236804Amphetamine Addiction1CTD_human
TgeneC0236807Amphetamine Abuse1CTD_human
TgeneC0238281Middle Cerebral Artery Syndrome1CTD_human
TgeneC0242379Malignant neoplasm of lung1CTD_human
TgeneC0269102Endometrioma1CTD_human
TgeneC0376280Anxiety States, Neurotic1CTD_human
TgeneC0393786Trigeminal Neuralgia, Idiopathic1CTD_human
TgeneC0393787Secondary Trigeminal Neuralgia1CTD_human
TgeneC0458247Allodynia1CTD_human
TgeneC0678222Breast Carcinoma1CTD_human
TgeneC0740376Middle Cerebral Artery Thrombosis1CTD_human
TgeneC0740391Middle Cerebral Artery Occlusion1CTD_human
TgeneC0740392Infarction, Middle Cerebral Artery1CTD_human
TgeneC0751111Awakening Epilepsy1CTD_human
TgeneC0751211Hyperalgesia, Primary1CTD_human
TgeneC0751212Hyperalgesia, Secondary1CTD_human
TgeneC0751213Tactile Allodynia1CTD_human
TgeneC0751214Hyperalgesia, Thermal1CTD_human
TgeneC0751217Hyperkinesia, Generalized1CTD_human
TgeneC0751845Middle Cerebral Artery Embolus1CTD_human
TgeneC0751846Left Middle Cerebral Artery Infarction1CTD_human
TgeneC0751847Embolic Infarction, Middle Cerebral Artery1CTD_human
TgeneC0751848Thrombotic Infarction, Middle Cerebral Artery1CTD_human
TgeneC0751849Right Middle Cerebral Artery Infarction1CTD_human
TgeneC1257931Mammary Neoplasms, Human1CTD_human
TgeneC1279420Anxiety neurosis (finding)1CTD_human
TgeneC1458155Mammary Neoplasms1CTD_human
TgeneC1862939AMYOTROPHIC LATERAL SCLEROSIS 11CTD_human
TgeneC1862941Amyotrophic Lateral Sclerosis, Sporadic1CTD_human
TgeneC2936719Mechanical Allodynia1CTD_human
TgeneC3495559Juvenile arthritis1CTD_human
TgeneC3714758Juvenile psoriatic arthritis1CTD_human
TgeneC3887506Hyperkinesia1CTD_human
TgeneC4551993Amyotrophic Lateral Sclerosis, Familial1CTD_human
TgeneC4552091Polyarthritis, Juvenile, Rheumatoid Factor Negative1CTD_human
TgeneC4704862Polyarthritis, Juvenile, Rheumatoid Factor Positive1CTD_human
TgeneC4704874Mammary Carcinoma, Human1CTD_human
TgeneC4704884Fibrocystic Dysplasia of Bone1CTD_human
TgeneC4704885Fibrocartilaginous Dysplasia of Bone1CTD_human
TgeneC4721610Carcinoma, Ovarian Epithelial1CTD_human